The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 5.00 (0.29%)
Spread: 0.50 (0.029%)
Open: 1,733.00
High: 1,739.50
Low: 1,724.50
Prev. Close: 1,728.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: US debt uncertainty persists, Footsie finishes under

Mon, 25th Jul 2011 16:42

The Footsie trimmed earlier gains as markets in the US recovered after a weak start. Despite falling as low as 5,893 on Monday, London's blue chip index finished firmly above the 5,900 mark, as giants BP, ARM, BG and GlaxoSmithKline rose ahead of their interim results due tomorrow. While stocks on Wall Street took a hit after the opening bell, the retreat wasn't as bad as many had expected, even though the nation is only eight days from a possible default. Investors continued "to call Washington's bluff" in regards to the debt ceiling talks, according to CNNMoney, which suggested that investors do not believe that government officials will allow the US to default on its debt.Meanwhile, the euro crisis raged on after ratings agency Moody's downgraded Greece's sovereign debt rating by three notches from Caa1 to Ca, a mere two stations above a rating that would signify a default. Investors are concerned that Spain and even Italy could be next in the firing line. Back in London on the FTSE 100, silver producer Fresnillo finished as a high riser on the back of a rising silver price, which increased by 0.74% to $40.42 at 16:44. Gold prices edged upwards also, as nervousness over the US debt talks boosted the safe-haven appeal of precious metals.The banks were among the worst performers as volatility in the sector continues amidst the ongoing euro crisis. Banking shares rallied on Thursday after European leaders agreed a new aid package for Greece and an overhaul of the Eurozone sovereign rescue fund. However, Barclays, RBS and Lloyds were all lower today as a result of concern about the future of the single currency. Insurers Aviva, Resolution, Admiral and Standard Life were also among the heavy fallers.Sector peers Melrose and Charter International were rising after Melrose said today that it is thinking over whether or not to up its bid for Charter after the target dismissed its first two offers. "Melrose is willing to consider increasing its proposal to reflect any information which demonstrates that it has materially undervalued Charter and justifies such an increase," the firm said. Dixons Retail was a heavy faller on the FTSE 250 after UBS downgraded the electricals retailer from "neutral" to "sell", saying that trading is "set to remain tougher for longer". The Swiss broker thinks that Dixons, which owns PC World and Currys, is likely to report a weak first quarter "given the tough World Cup comparative [of last year] but we expect [the second half] to remain tough". Leading the risers was pizza delivery group Domino's Pizza, after it posted a sharp rise in first-half profits in the first half of the year despite the tough economic climate. BCFTSE 100 - RisersFresnillo (FRES) 1,729.00p +2.86%Weir Group (WEIR) 2,210.00p +2.55%United Utilities Group (UU.) 598.00p +1.70%GlaxoSmithKline (GSK) 1,363.50p +1.68%Burberry Group (BRBY) 1,600.00p +1.39%Capital Shopping Centres Group (CSCG) 386.10p +1.39%Reckitt Benckiser Group (RB.) 3,526.00p +1.38%GKN (GKN) 238.20p +1.15%BG Group (BG.) 1,425.00p +1.10%Hammerson (HMSO) 477.10p +1.10%FTSE 100 - FallersBarclays (BARC) 228.95p -4.44%Lloyds Banking Group (LLOY) 45.10p -4.30%Aviva (AV.) 412.60p -3.01%Resolution Ltd. (RSL) 281.90p -2.32%Hargreaves Lansdown (HL.) 596.00p -2.05%Admiral Group (ADM) 1,562.00p -2.01%Autonomy Corporation (AU.) 1,662.00p -1.71%Cairn Energy (CNE) 386.80p -1.58%Royal Bank of Scotland Group (RBS) 36.28p -1.57%Vodafone Group (VOD) 162.00p -1.55%
More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.